151 related articles for article (PubMed ID: 20674062)
1. Physiologic insulin delivery with insulin feedback: a control systems perspective.
Palerm CC
Comput Methods Programs Biomed; 2011 May; 102(2):130-7. PubMed ID: 20674062
[TBL] [Abstract][Full Text] [Related]
2. Closed-loop insulin delivery - what lies between where we are and where we are going?
Steil GM; Rebrin K
Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
[TBL] [Abstract][Full Text] [Related]
3. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
4. Induced L₂-norm minimization of glucose-insulin system for Type I diabetic patients.
Kovács L; Benyó B; Bokor J; Benyó Z
Comput Methods Programs Biomed; 2011 May; 102(2):105-18. PubMed ID: 20674065
[TBL] [Abstract][Full Text] [Related]
5. Neural network modeling and control of type 1 diabetes mellitus.
El-Jabali AK
Bioprocess Biosyst Eng; 2005 Apr; 27(2):75-9. PubMed ID: 15578231
[TBL] [Abstract][Full Text] [Related]
6. [From external to implantable insulin pump, can we close the loop?].
Renard E; Costalat G; Bringer J
Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
[TBL] [Abstract][Full Text] [Related]
7. Closed-loop control of artificial pancreatic Beta -cell in type 1 diabetes mellitus using model predictive iterative learning control.
Wang Y; Dassau E; Doyle FJ
IEEE Trans Biomed Eng; 2010 Feb; 57(2):211-9. PubMed ID: 19527957
[TBL] [Abstract][Full Text] [Related]
8. An Improved PID Algorithm Based on Insulin-on-Board Estimate for Blood Glucose Control with Type 1 Diabetes.
Hu R; Li C
Comput Math Methods Med; 2015; 2015():281589. PubMed ID: 26550021
[TBL] [Abstract][Full Text] [Related]
9. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
[TBL] [Abstract][Full Text] [Related]
10. Fuzzy-based controller for glucose regulation in type-1 diabetic patients by subcutaneous route.
Campos-Delgado DU; Hernández-Ordoñez M; Femat R; Gordillo-Moscoso A
IEEE Trans Biomed Eng; 2006 Nov; 53(11):2201-10. PubMed ID: 17073325
[TBL] [Abstract][Full Text] [Related]
11. Artificial neural networks for closed loop control of in silico and ad hoc type 1 diabetes.
Fernandez de Canete J; Gonzalez-Perez S; Ramos-Diaz JC
Comput Methods Programs Biomed; 2012 Apr; 106(1):55-66. PubMed ID: 22178070
[TBL] [Abstract][Full Text] [Related]
12. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
[TBL] [Abstract][Full Text] [Related]
13. An insulin infusion advisory system based on autotuning nonlinear model-predictive control.
Zarkogianni K; Vazeou A; Mougiakakou SG; Prountzou A; Nikita KS
IEEE Trans Biomed Eng; 2011 Sep; 58(9):2467-77. PubMed ID: 21622071
[TBL] [Abstract][Full Text] [Related]
14. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
Pfützner A; Berger S; Spinas G
Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
[TBL] [Abstract][Full Text] [Related]
15. Multicomponent system for normoglycemic insulin substitution in type 1 diabetic outpatients.
Howorka K; Stöhr H; Thoma H; Waldhäusl W
Life Support Syst; 1985; 3 Suppl 1():540-5. PubMed ID: 3916618
[No Abstract] [Full Text] [Related]
16. A fuzzy logic based closed-loop control system for blood glucose level regulation in diabetics.
Ibbini MS; Masadeh MA
J Med Eng Technol; 2005; 29(2):64-9. PubMed ID: 15804854
[TBL] [Abstract][Full Text] [Related]
17. Not the artificial beta cell algorithms but their parameter values are important in automated glucose control of insulin-dependent diabetes.
Fischer U; Jutzi E; Albrecht G; Abel P; Salzsieder E; Freyse EJ; Detscheff W; Lemke K
Trans Am Soc Artif Intern Organs; 1983; 29():488-91. PubMed ID: 6673274
[TBL] [Abstract][Full Text] [Related]
18. Neonatal diabetes and insulin pump therapy.
Beardsall K; Pesterfield CL; Acerini CL
Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F223-4. PubMed ID: 21115555
[TBL] [Abstract][Full Text] [Related]
19. Long-term application of wearable artificial endocrine pancreas--closed-loop intravenous vs subcutaneous insulin infusion.
Shichiri M; Kawamori R; Goriya Y; Yamasaki Y; Nomura M; Asakawa N; Kubota M; Kamada T
Life Support Syst; 1985; 3 Suppl 1():583-7. PubMed ID: 3916624
[TBL] [Abstract][Full Text] [Related]
20. An improved PID switching control strategy for type 1 diabetes.
Marchetti G; Barolo M; Jovanovic L; Zisser H; Seborg DE
IEEE Trans Biomed Eng; 2008 Mar; 55(3):857-65. PubMed ID: 18334377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
